nelfinavir has been researched along with Black Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrillo, E; Mejías, F; Moreno, J; Sánchez, C; Valdivieso, E | 1 |
| Garg, R; Messier, N; Ouellette, M; Sundar, S; Tremblay, MJ; Trudel, N | 1 |
2 other study(ies) available for nelfinavir and Black Fever
| Article | Year |
|---|---|
Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Survival; Disease Models, Animal; Drug Synergism; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Mice, Inbred BALB C; Nelfinavir; Parasite Load; Phosphorylcholine; Spleen; Treatment Outcome | 2018 |
Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors.
Topics: Animals; Cell Line, Tumor; HIV Protease Inhibitors; Humans; Leishmania; Leishmaniasis, Visceral; Lethal Dose 50; Macrophages; Nelfinavir; Ritonavir; Saquinavir | 2008 |